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Discussion – Ecological challenges concerning the use of
genetically modified mosquitoes for disease control:
synthesis and future perspectives
Bart G.J. Knols and Thomas W. Scott
The preceding chapters of this book focus on ecological aspects for the application
of genetically modified mosquitoes for disease control. Although the novelty of the
approach to render disease vectors incapable of transmitting some of the world’s most
debilitating diseases is underscored and unanimously recognized in these
contributions, it is clear at the same time that the authors’ views on the topic of
feasibility are controversial and deserve continued debate. Being the first of its nature,
the ‘Wageningen Meeting’ as it has become known, marked the beginning of a
renewed impetus towards enhancing the still trifling knowledge on the ecology and
behaviour of major Anopheles and Aedes disease vectors. The recognition of this
knowledge gap by the wider scientific community and funding agencies alike will
hopefully follow, and in itself presents ample justification for the publication of this
volume.
A second important outcome of the meeting was the recognition that scientific
expertise in countries earmarked for future application of novel vector-control
interventions is sorely lacking. Not only do those countries often have limited
scientific capability overall, their capacity in terms of research on the basic ecology
and population biology of disease vectors is even less advanced. In spite of various
ongoing international initiatives to improve this situation (Killeen et al. 2002), it will
require additional efforts to enthuse young scientists in disease-endemic countries to
engage in the study of vector biology and infectious-disease control. Failure to
establish a competent cadre of scientists and absence of their involvement, through
full partnership in decision-making processes and research alike, will be an
impediment to improving public health and merely result in the repetition of past
mistakes (Desowitz 1993). Fortunately, it is widely agreed that one should proceed
with genetically modified mosquito field trials only if the likelihood of public-health
benefits can be maximized, potential adverse effects for humans and the environment
can be minimized, and the advance of this endeavour includes full collaboration with
scientists in endemic countries (Alphey et al. 2002; Scott et al. 2002).
The third common denominator in the preceding contributions is the fact that
advances in the understanding of ecological processes that affect mosquito
populations and transmission of disease will be of value to any intervention
methodology, be it the ones that are currently advocated (for example, insecticide-
treated bed nets) or those that are being developed to augment existing methodology,
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like genetically modified mosquitoes. Critical in this regard, particularly in the case of
malaria in sub-Saharan Africa, will be the divergence from the intradomiciliary to the
peridomestic domain. The ‘ease’ of targeting host-seeking female vectors indoors, by
using residual insecticides on the walls and roofs of houses or on bed-net material,
curtains etc. will not apply to interventions that aim to reduce mosquito populations in
open-field settings. This historical focus (on the indoor environment) is probably the
leading cause for a still marginal understanding of vector population biology, the
underlying causes for observed dynamics in populations, and the forces that drive
such processes as dispersal, mating patterns, and speciation. Some of the intricacies of
peridomestic anopheline life history remain a mystery such as dry-season survival, the
nature of precopulatory mating barriers and male feeding behaviour, to name but a
few. Similar knowledge gaps exist for Aedes aegypti ecology, population biology, and
its role in transmission of dengue and yellow-fever viruses. A myriad of questions that
have surfaced in this volume relate to these critical understudied topics. Consequently,
an important research need is to understand these processes in order to maximize the
likelihood of success for any intervention that targets vectors in the peridomestic
domain, including genetic-control strategies.
Another major issue for concern when moving away from the intradomiciliary
domain will be the shift from individual-based intervention technology to community-
wide applications. The release of genetically modified or sterile insects will require
consent at the community level, which is in stark contrast to existing methodologies
whereby individuals can simply decide whether or not to use such tools as an
insecticidal mosquito coil or bed net. What will happen if the old man under the tree
will not tolerate the release of genetically modified insects? Although such social and
ethical issues were not discussed at length (but see Touré et al. in this volume) either
during the Wageningen meeting (Scott et al. 2002) or the London meeting that
preceded it (Alphey et al. 2002), such controversies will ultimately be a significant
challenge for the application of peridomestic intervention technologies (including
genetic as well as non-genetic approaches, like larval control). Although it has been
repeatedly stated in this book that ecological knowledge lags behind advances in
molecular entomology, it is perhaps the sociological perspective that needs as much,
if not more attention to ensure support and goodwill at all levels. It will be essential in
areas earmarked for application to have support ranging from the affected
communities to their country’s public-health authorities (Aultman, Beaty and Walker
2001; Touré et al. in this volume).
Nevertheless, historical attempts to apply mosquito genetic-control strategies to
reduce vector populations and curb disease transmission show that communities and
governments of countries like Myanmar, Pakistan, El Salvador and Kenya, and
European and US donor agencies have been supportive of such programmes. For
years Zanzibar supported mass releases of sterile tsetse flies (Glossina austeni), which
led to eventual eradication of this species from that island (Msangi et al. 2000).
Whether similar support can be generated for the release of genetically modified
mosquitoes remains to be seen. More important at this stage is that appropriate lessons
have been learned from past experiences. Although some failures could be attributed
to factors other than those related to the technology applied, like the outbreak of civil
war in El Salvador, which led to the abandonment of the SIT programme with
Anopheles albimanus, most failures were attributed to insufficient understanding of
the ecology of wild mosquito populations and the fate of released material. Although
such programmes were staged over two decades ago, these same hurdles still need to
be overcome today, and specifically centre on the lack of knowledge in four areas:
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1. Male biology. Historically, control efforts have focused on female mosquitoes,
because they transmit pathogens that cause disease. A consequence of this is
that knowledge of male life history is limited. Dependence of males on
nutrients from plants, and how availability thereof affects survival and fitness,
is a key element in genetic-control strategies yet thorough understanding of
that kind of information is lacking. The factors that govern swarm formation,
sustenance, and mate choice are similarly relatively unknown. Considering the
fact that releases of female insects will likely be regarded as unethical (due to
their blood-feeding habit), it will be parameters like those mentioned above
that directly affect the efficient transmission of transgenes or sterile sperm
from released males to wild females.
2. Mating behaviour. Although it is generally assumed that anophelines mate at
swarm sites, apparent absence thereof in several areas where researchers have
spent considerable time searching for them, suggests that other mating
strategies may exist. It will be critical to ascertain whether or not this is the
case. Similarly, do male Ae. aegypti locate and mate with females when they
are not engaged in flight around human hosts? Do anopheline and Aedes
mosquitoes mate assortatively? If so, based on what information are those
choices made? Segregation mechanisms that keep hybridization between
sibling species to a minimum, and even yield substantial reproductive isolation
between chromosomal and molecular forms of An. gambiae sensu stricto have
been recorded (e.g. Wondji, Simard and Fontenille 2002; Della Torre et al.
2002). Although the merits of molecular medical entomology may at times be
questioned (Curtis 2002), molecular taxonomy has played a key role in
defining reproductive isolation between sympatric populations of what was
thought to be one taxon just years earlier. This information is vital for any
genetic-control strategy because even a small population not targeted by the
intervention may, due to reproductive isolation, undermine the benefits of
releases by maintaining disease incidence and parasite prevalence at or close to
pre-intervention levels.
3. Colonization and mass-production effects. The transition of wild mosquitoes
to insectary conditions, more so for anophelines than for Ae. aegypti, is
difficult and frequently fails. Mating, particularly in small-cage conditions
(stenogamy) rather than through swarm formation outdoors, exerts a strong
selection pressure for genotypes that thrive in such artificial conditions and
hence causes a reduction in genome diversity. The build-up of subsequent
generations and mass production for release was reported to result in reduced
mating competitiveness (see Reisen in this volume). Non-compromised mating
ability and adult survival are two critical elements for the success of genetic-
control strategies. The impact of colonization and mass rearing deserves more
thorough investigation. Similarly, behavioural determinants of gene flow in
mosquito populations and the influence thereon of laboratory maintenance
require intensive investigation in order to establish quality-control protocols
for mosquitoes earmarked for release.
4. Population biology. Population biology issues will strongly impact genetic-
control strategies. Investigators involved in several previous attempts to apply
genetic-control techniques for disease control attributed failure to limited
understanding of the ‘background’ population into which altered insects were
introduced. Classical approaches, such as mark-release-recapture were utilized
to determine ratios at which released insects should be introduced into wild
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populations. Yet, some of the more critical components that will affect
transgene technology, such as the factors that determine the spatial and
temporal variations of allele frequencies and affect population structure, have
only been studied to a limited extent. For example, dynamics of seemingly
village-bound subpopulations of highly anthropophilic mosquitoes across
fragmented landscapes support the need for a more thorough understanding of
mosquito metapopulations. This will, however, constitute a significant
scientific challenge because of complications associated with fluctuations in
gene flow among ‘patches’ of mosquitoes and variation within (seasonal) and
among effective population sizes (see Taylor and Manoukis in this volume).
Advances in the above four areas of research will be of tremendous value in
assessing the likelihood of success when applying genetic-control strategies.
Additional, yet salient issues that need to be taken into account relate to geographical
differences in the vectorial systems that influence transmission dynamics of disease.
Some countries, like Cameroon, have incriminated five endemic anopheline species as
malaria vectors, whereas others, like the islands of São Tomé and Principe and
Réunion report just one (potential) vector species. Anopheles funestus Giles sustains
intense (seasonal) transmission in many African countries alongside its An. gambiae
s.l. counterpart, yet its inclusion in genetic-control programmes remains exceedingly
difficult due to difficulties of maintaining this species in the laboratory. It is
imperative, therefore, that the biology and life history of this epidemiologically
important species receives increased attention, if genetic-control strategies are to be
scaled-up in the future to go beyond the highly specific ecological or physical island
settings now under consideration. Although not equal contributors to transmission of
dengue and other arboviruses, Aedes aegypti and Ae. albopictus also can transmit
viruses sympatrically, which raises similar concerns to the malaria situation for the
application of genetic-control tools when multiple species of mosquito vectors are
present in the same geographic location.
Some recently developed novel transgenic approaches for insect control were
discussed briefly in this volume (see Curtis 2003), like application of dominant
lethality or engineered underdominance. Such approaches may ultimately be
employed to control mosquito vectors. However, the bulk of research to date, and the
main focus of discussion in this book, relates to the ecological consequences of
attachment of an antipathogenic genetic construct to an efficient genetic-drive
mechanism, introduced through mosquito germline transformation, followed by the
release of such genetically modified mosquitoes into the environment. Although this
concept is not new (Curtis 1968), its full development has only come to flourish over
the last decade, when appropriate advances in molecular biology facilitated its full
application. Proof of principle, with impaired transmission capability of mosquitoes
for both malaria (Ito et al. 2002) and dengue transmission (Olson et al. 1996), has
been established, and has generated considerable excitement that this approach may
come to fruition for use as a public-health tool. Before such advances can be
expected, however, there are several important issues that need to be addressed.
Considering the fact that progress to date has been confined to laboratory settings,
a myriad of unanswered questions relate to the fate of engineered mosquitoes in the
natural environment. In view of the potential for detrimental effects of parasite
infection on mosquito fitness (Hurd 2003) one would expect refractoriness to be a trait
of high adaptive value, yet it is rare in field populations (Schwartz and Koella 2002).
The staging of an effective immune response may, therefore, bear an evolutionary
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cost too high for it to become naturally fixed, which explains the need for a highly
effective drive mechanism to increase introduced gene frequency in wild populations.
Concern has risen over the physiological consequences and altered mosquito resource
allocation in response to introduction of a refractory trait, and the possible
unfavourable selection pressure against such genotypes. If not carefully designed and
implemented, inclusion of transgenes in the mosquito genome may at best yield
complete blockage of pathogen development in the individuals possessing the trait,
but may compromise mosquito fitness to the extent that such traits rapidly disappear
from the target population (Billingsley; Koella in this volume; Catteruccia, Godfray
and Crisanti 2003; Boëte and Koella 2003). Another pertinent issue with regard to the
above concerns relates to the use of a genetic-drive mechanism (e.g. a transposon) to
overcome the selective disadvantage of possessing transgenes. If a transgene that
reduces fitness disassociates from its genetic driver, the transgene and its beneficial
effect on pathogen transmission will be lost.
It is generally accepted that if wild mosquito populations are to be replaced with
refractory ones, drive mechanisms are required to spread transgenes at rates that
exceed the spread of genes by normal Medelian heritance. If such a system can be
identified, then small ‘seeding’ releases of, for example, transposon-carrying
individuals may be adequate to accomplish population replacement. Alternatively
inundative releases could be repeated over time, but this would add logistical
complexity that may render it economically unviable in comparison to established
vector-control tools. The lessons learned from sterile-insect-technique programmes
will certainly be of value in this regard (Benedict and Robinson in press).
It has been suggested that an ecologically appropriate and biologically safe way to
address questions about the transfer of transposon-driven transgenic mosquitoes from
the laboratory to the field is to use contained semi-field systems (Aultman, Beaty and
Walker 2001; Scott et al. 2002). For some research topics this approach might work
well, for others it may not be appropriate due to inherent limitations (Knols et al. in
thsi volume). For instance, it may be inappropriate for studying the occurrence of
transgene inactivation through mutation, phenotypic expression in the genetic
background of wild populations or the development of pathogen-resistance against
introduced traits. Those processes are unlikely to be expressed and identified in small-
scale greenhouse studies over a short period of time. Other means will be required to
obtain that kind of critical information for the use of transgene technology when
applied on a large scale and over several years.
If the process of population replacement is complete and refractoriness absolute,
the merits of the transgenic approach will be easily identifiable – transmission will be
eliminated and disease will disappear. However, any shortfall of complete blockage of
transmission or partial population replacement will require detailed insight, which
does not currently exist, into the relationship between entomological risk and disease
outcome. Although the relationship between vector density, transmission intensity and
disease are fairly well understood for malaria (e.g. Smith, Leuenberger and Lengeler
2001), it has proven much harder to define such characteristics in the case of dengue
(Scott and Morrison in this volume). Measuring the direct public-health benefits of
transgene technology may likely be complex. An extension of this concern are the
possible consequences that reductions in pathogen transmission and delayed
acquisition of (partial) immunity may have on severity of disease. Although this so-
called ‘rebound effect’ has not been observed in bed-net studies in Tanzania (Maxwell
et al. 2002; Curtis in this volume) it remains to be seen whether these observations are
universal across wider ranges of transmission intensity and over longer time periods
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than have been studied to date. Overall, there is a fundamental need for improved
understanding of the intricate relationships between entomological indices of risk,
transmission intensity and dynamics, and disease incidence and prevalence.
Legitimate concerns have been raised regarding the various biosafety and risk
factors involved in the application of transgenic tools in agriculture and human health.
We, therefore, can anticipate that public concern over the inclusion of selected traits
in the genome of human-blood feeding, pathogen transmitting, and free-ranging
insects may be of similar if not larger magnitude compared with that observed for
biotechnologically enhanced food crops. An array of ethical, legal and social issues
related to the release of genetically modified mosquitoes must be addressed, in
conjunction will clearly defined biosafety and risk-assessment studies. Such studies
should include vector competence of target insects for diseases other than those
against which they were intended to be refractory. The merits of population
replacement should also be viewed with regard to sustained transmission potential of
other diseases by the target population (e.g. malaria-refractory An. gambiae
transmitting bancroftian filariasis). Above all, regulatory bodies charged with the
authorization process of moving transgene technology from the laboratory to full field
application, need to be established and should safeguard the two-pronged objective of
this endeavour: maximizing the likelihood of public-health benefits and minimizing
potential adverse effects for humans and the environment.
The Wageningen Meeting brought together a group of leading international experts
in the fields of mosquito biology and ecology, infectious-disease control and
epidemiology. The many stimulating discussions at the meeting were covered by
news features in Nature (Clarke 2002) and Science (Enserink 2002). In highlighting
the huge and intolerable burden of malaria and dengue it was once more noted that the
battle staged by mankind against their mosquito vectors is far from won, and leaves
many of the poorest nations in the world with insufficient capability to combat disease
and halt the economic losses they incur. The expanding global efforts, both in
scientific and financial terms, to turn the tide of this public-health disaster are to be
applauded. Major advances, notably the completion of the An. gambiae and
Plasmodium falciparum genome projects, offer prospects for expanding the arsenal of
novel tools (drugs, vaccines, insecticides) to combat malaria. We hope that the
ongoing Ae. aegypti genome project will result in similar positive public-health
impacts against dengue. Further refinement of insect transgenic technology and
identification of additional targets (phenotypes other than refractoriness such as
altered blood-feeding behaviour or shortened life span) capable of reducing a
mosquito population's capacity to transmit pathogens are to be expected over the
coming decade. Moreover, novel developments in the field of molecular biology will
in all likelihood deliver the means to circumvent impediments to application that exist
today.
‘Ecological aspects for application of genetically modified mosquitoes’ is the first
scientific contribution to draft a research agenda specifically intended to facilitate the
application of novel (genetic) approaches to reduce or element mosquito-borne
disease. Given the appropriate financial, scientific, and human resources, we may
indeed enter an era rich in successes and unprecedented in scale and magnitude,




Alphey, L., Beard, C.B., Billingsley, P., et al., 2002. Malaria control with genetically
manipulated insect vectors. Science, 298 (5591), 119-121.
Aultman, K.S., Beaty, B.J. and Walker, E.D., 2001. Genetically manipulated vectors
of human disease: a practical overview. Trends in Parasitology, 17 (11), 507-
509.
Benedict, M.Q. and Robinson, A.S., in press. The first releases of transgenic
mosquitoes: an argument for the sterile insect technique. Trends in
Parasitology.
Billingsley, P.F., 2003. Environmental constraints on the physiology of transgenic
mosquitoes. In: Takken, W. and Scott, T. W. eds. Ecological aspects for
application of genetically modified mosquitoes. Kluwer Academic Publishers,
Dordrecht. Frontis series no. 2.
Boëte, C. and Koella, J.C., 2003. Evolutionary ideas about genetically manipulated
mosquitoes and malaria control. Trends in Parasitology, 19 (1), 32-38.
Catteruccia, F., Godfray, H.C.J. and Crisanti, A., 2003. Impact of genetic
manipulation on the fitness of Anopheles stephensi mosquitoes. Science, 299
(5610), 1225-1227.
Clarke, T., 2002. Mosquitoes minus malaria. Nature, 419 (6906), 429-430.
Curtis, C.F., 1968. Possible use of translocations to fix desirable genes in insect pest
populations. Nature, 218, 368-369.
Curtis, C.F., 2002. Molecular medical entomology and the 'so what?' test. Trends in
Ecology and Evolution, 17 (2), 102.
Curtis, C.F., 2003. Measuring public-health outcomes of release of transgenic
mosquitoes. In: Takken, W. and Scott, T. W. eds. Ecological aspects for
application of genetically modified mosquitoes. Kluwer Academic Publishers,
Dordrecht. Frontis series no. 2.
Della Torre, A., Costantini, C., Besansky, N.J., et al., 2002. Speciation within
Anopheles gambiae - the glass is half full. Science, 298 (5591), 115-117.
Desowitz, R.S., 1993. The malaria capers: tales of parasites and people. W.W.
Norton & Company, Inc., New York.
Enserink, M., 2002. Malaria : ecologists see flaws in transgenic mosquito. Science,
297 (5578), 30-31.
Hurd, H., 2003. Manipulation of medically important insect vectors by their parasites.
Annual Review of Entomology, 48, 141-161.
Ito, J., Ghosh, A., Moreira, L.A., et al., 2002. Transgenic anopheline mosquitoes
impaired in transmission of a malaria parasite. Nature, 417 (6887), 452-455.
Killeen, G.F., Knols, B.G.J., Fillinger, U., et al., 2002. Interdisciplinary malaria vector
research and training for Africa. Trends in Parasitology, 18 (10), 433-434.
Knols, B.G.J., Njiru, B.N., Mukabana, R.W., et al., 2003. Contained semi-field
environments for ecological studies on transgenic African malaria vectors:
benefits and constraints. In: Takken, W. and Scott, T. W. eds. Ecological
aspects for application of genetically modified mosquitoes. Kluwer Academic
Publishers, Dordrecht. Frontis series no. 2.
Koella, J.C., 2003. On the evolutionary ecology of mosquito immunity and the use of
transgenic mosquitoes for malaria control. In: Takken, W. and Scott, T. W.
eds. Ecological aspects for application of genetically modified mosquitoes.
Kluwer Academic Publishers, Dordrecht. Frontis series no. 2.
Chapter 18
242
Maxwell, C.A., Msuya, E., Sudi, M., et al., 2002. Effect on malaria morbidity of
community-wide use in Tanzania of insecticide treated nets for 3-4 years.
Tropical Medicine and International Health, 7 (12), 1003-1008.
Msangi, A.R., Saleh, K.M., Kiwia, N., et al., 2000. Success in Zanzibar: eradication of
tsetse. In: Tan, K.-H. ed. Area-wide control of fruit flies and other insect pests.
Penerbit Universiti Sains Malaysia, Pulau Penang, 57-66.
Olson, K.E., Higgs, S., Gaines, P.J., et al., 1996. Genetically engineered resistance to
dengue-2 virus transmission in mosquitoes. Science, 272 (5263), 884-886.
Reisen, W.K., 2003. Lessons from the past: historical studies by the University of
Maryland and the University of California, Berkeley. In: Takken, W. and
Scott, T. W. eds. Ecological aspects for application of genetically modified
mosquitoes. Kluwer Academic Publishers, Dordrecht. Frontis series no. 2.
Schwartz, A. and Koella, J.C., 2002. Melanization of Plasmodium falciparum and c-
25 sephadex beads by field-caught Anopheles gambiae (Diptera: Culicidae)
from southern Tanzania. Journal of Medical Entomology, 39 (1), 84-88.
Scott, T.W. and Morrison, A., 2003. Aedes aegypti density and the risk of dengue-
virus transmission. In: Takken, W. and Scott, T. W. eds. Ecological aspects
for application of genetically modified mosquitoes. Kluwer Academic
Publishers, Dordrecht. Frontis series no. 2.
Scott, T.W., Takken, W., Knols, B.G.J., et al., 2002. The ecology of genetically
modified mosquitoes. Science, 298 (5591), 117-119.
Smith, T.A., Leuenberger, R. and Lengeler, C., 2001. Child mortality and malaria
transmission intensity in Africa. Trends in Parasitology, 17 (3), 145-149.
Taylor, C.E. and Manoukis, N.C., 2003. Effective population size in relation to
genetic modification of Anopheles gambiae sensu stricto. In: Takken, W. and
Scott, T. W. eds. Ecological aspects for application of genetically modified
mosquitoes. Kluwer Academic Publishers, Dordrecht. Frontis series no. 2.
Touré, Y.T., Oduola, A.M.J., Sommerfeld, J., et al., 2003. Biosafety and risk
assessment in the use of genetically modified mosquitoes for disease control.
In: Takken, W. and Scott, T. W. eds. Ecological aspects for application of
genetically modified mosquitoes. Kluwer Academic Publishers, Dordrecht.
Frontis series no. 2.
Wondji, C., Simard, F. and Fontenille, D., 2002. Evidence for genetic differentiation
between the molecular forms M and S within the Forest chromosomal form of
Anopheles gambiae in an area of sympatry. Insect Molecular Biology, 11 (1),
11-19.
